How physiologically based pharmacokinetic models should be improved for drug development
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 12(2020), 12 vom: 30. Juni, Seite 1107-1109 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hempel, Georg [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antimicrobial drugs |
|---|
| Anmerkungen: |
Date Completed 21.05.2021 Date Revised 21.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2020-0074 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309333466 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309333466 | ||
| 003 | DE-627 | ||
| 005 | 20231225133701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2020-0074 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309333466 | ||
| 035 | |a (NLM)32349520 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hempel, Georg |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How physiologically based pharmacokinetic models should be improved for drug development |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.05.2021 | ||
| 500 | |a Date Revised 21.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a antimicrobial drugs | |
| 650 | 4 | |a drug development | |
| 650 | 4 | |a drug metabolism | |
| 650 | 4 | |a infectious disease therapeutics | |
| 650 | 4 | |a pharmacokinetics/pharmacodynamics | |
| 650 | 4 | |a pharmacology | |
| 650 | 4 | |a systems biology | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 12(2020), 12 vom: 30. Juni, Seite 1107-1109 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |g number:12 |g day:30 |g month:06 |g pages:1107-1109 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2020-0074 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2020 |e 12 |b 30 |c 06 |h 1107-1109 | ||